Avoid common mistakes on your manuscript.
Balloon pulmonary angioplasty (BPA) improves hemodynamics by dilating organized thrombi using a balloon and is becoming a therapeutic method for the distal type of chronic thromboembolic pulmonary hypertension (CTEPH) [1]. In BPA, a smaller balloon is typically selected and dilates as many vessels as possible in the first session and a larger balloon for subsequent sessions [2] while there are no clear criteria for determining balloon size.
A 46-year-old man was referred to our hospital for treatment of CTEPH with dyspnea for six months. His mean pulmonary artery pressure (mPAP) was 43 mmHg, indicating distal type of CTEPH based on pulmonary angiography. BPA was selected as the therapeutic method after administration of vasodilator. Optical coherence tomography (OCT) can reveal the precise morphology of organized thrombi [3], and we used OCT to evaluate the efficacy of balloon dilatation. In the first session of the right lung, we observed web lesion of the posterior ascending branch (Fig. 1A, Supplemental Video 1). The vessel diameter (VD) was 3.0 × 2.9 mm (Fig. 1B) which did not change the reference VD of the proximal site (3.4 × 2.9 mm), and we dilated with a 3.0 mm balloon. After dilatation, the ratio of wire lumen area to vessel area (RWV) was enlarged (from 0.41 to 0.49) (Fig. 1C). He underwent another BPA session to the left lung. In the second session to the right lung six weeks later, his mPAP improved to 23 mmHg. The VD of lesion and reference were almost unchanged (lesion: 3.1 × 2.5 mm, Fig. 1D, reference: 3.2 × 2.3 mm), however, RWV was increased (0.65). To increase blood flow, we dilated with a larger-sized balloon of 4.0 mm; VD after dilatation did not change (3.0 × 2.7 mm), while RWV was increased (from 0.65 to 0.88) and the organized thrombus was tightly compressed (Fig. 1E). This indicates that the organized thrombus could be expanded without vessel over-expansion, and the blood flow improved with visible venous return (Supplemental Video 2). Serial OCT findings were summarized in Table 1. An additional BPA session to the left lung vessels was performed. The mPAP measured after four sessions, two sessions on each side of the lung, improved to 18 mmHg. His clinical and hemodynamic parameters were shown in Table 2.
In BPA, selecting the appropriate balloon size is crucial, as using a balloon that is too small can reduce treatment efficacy while using one that is too large can lead to pulmonary hemorrhage due to over-expansion [4]. While there is a suggestion using the diameter of the proximal site as a reference for balloon size selection [5], there is no standardized approach. The organized thrombi in CTEPH are usually stiff such as fibrous webs, dilation with a balloon approximately 1 mm oversize than the proximal reference diameter might be more effective in compressing organized thrombus and increasing blood flow, especially in cases with relatively stable hemodynamics (e.g., mPAP < 30 mmHg). To more effectively improve hemodynamics with fewer BPA sessions, further research is needed to determine the optimal approach for selecting balloon size.
References
Humbert M, Kovacs G, Hoeper MM, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2022;2023:61.
Shimokawahara H, Ogawa A, Matsubara H. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection. Curr Opin Pulm Med. 2021;27:303–10.
Coghlan JG, Rothman AM, Hoole SP. Balloon pulmonary angioplasty: state of the art. Interv Cardiol. 2020;16: e02.
Ogawa A, Matsubara H. After the dawn–balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension. Circ J. 2018;82:1222–30.
Matsubara H, Ogawa A. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: modern technique. Balloon pulmonary angioplasty in patients with CTEPH: Springer; 2022:35–44.
Acknowledgements
None
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent for Publication
Consent for publication was obtained for every individual person’s data included in the study.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Initial angiogram of target vessel (MP4 1031 kb)
Angiogram of target vessel after 4.0mm balloon dilatation (MP4 445 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Minatsuki, S., Hatano, M., Tanikawa, I. et al. Verification of Optimal Balloon Size in Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Cardiovasc Intervent Radiol 46, 967–969 (2023). https://doi.org/10.1007/s00270-023-03489-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03489-9